U.S. Medical Device Manufacturers Market Summary

The U.S. medical device manufacturers market size was estimated at USD 256.2 billion in 2024 and is projected to grow at a CAGR of 5.9% from 2025 to 2030. Market growth is supported by several key factors, including the rising geriatric population, increasing adoption of minimally invasive procedures, a higher incidence of sports and road accidents, and the expanding geographic reach of leading manufacturers. The growing burden of chronic illnesses within the elderly population continues to boost demand for innovative medical technologies, while advancements in surgical techniques and device design are reinforcing adoption. According to a USA Today news article, fatal car crashes rose steadily from 36,835 in 2018 to an estimated 42,795 in 2022, further driving the demand for trauma and emergency care devices.

The U.S. medical device manufacturers market is further benefiting from geographic expansion strategies and divestiture from non-core businesses. Market players are increasingly leveraging acquisitions, partnerships, and collaborations to extend their reach into new territories, tap wider customer bases, and strengthen innovation capabilities. A notable example includes Abbott’s acquisition of Cardiovascular Systems, Inc. (CSI) in February 2023, which represented a significant consolidation in the cardiovascular device segment. The acquisition, valued at approximately USD 890 million, enhanced Abbott’s portfolio and presence in the high-demand cardiovascular device industry. Such expansions and mergers are expected to continue shaping the competitive landscape in the coming years.

Key Market Trends & Insights

• The others segment led the U.S. medical device manufacturers market, accounting for 35.7% of the revenue in 2024. This category includes devices used in in-vitro diagnostics (IVD), medical imaging, dental care, ear-nose-and-throat (ENT) applications, wound care, and general surgical procedures. Demand for dental devices remains particularly strong due to the rising prevalence of tooth loss. According to Midwestern University Clinics, over 36 million U.S. citizens are currently edentulous, while an additional 120 million are missing at least one tooth. These statistics underscore the importance of dental technologies in enhancing patient outcomes and quality of life.
• Within the others category, the ENT devices segment is also witnessing robust demand. The increasing need for advanced otolaryngology solutions is driving the adoption of technologies that provide improved diagnostic precision and therapeutic effectiveness. Innovations in imaging, surgical navigation, and minimally invasive ENT procedures are expected to create new growth avenues, reflecting the sector’s transition toward high-performance, patient-friendly solutions.
• Cardiology devices are expected to register the fastest CAGR of 7.7% during the forecast period. Cardiovascular diseases remain a leading cause of death in the U.S., with alarming mortality rates. According to the CDC, as of May 2023, one death due to cardiovascular disease occurs every 33 seconds. This creates a strong demand for innovative cardiology devices that can support prevention, facilitate early diagnosis, and provide effective treatment for life-threatening conditions. With continuous innovation in stents, implants, monitoring equipment, and minimally invasive cardiovascular procedures, this segment is projected to remain one of the most dynamic areas in the market.

Order a free sample PDF of the U.S. Medical Device Manufacturers Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 256.2 billion
• 2030 Projected Market Size: USD 9.44 billion
• CAGR (2025 - 2030): 5.9%

Key Companies & Market Share Insights

Several key players dominate the U.S. medical device manufacturers market, including Stryker, Medtronic, and Abbott.

Stryker is a leading global company specializing in a wide range of products, including powered surgical instruments, joint replacement systems, spinal and micro implant devices, trauma products, orthobiologics, endoscopic equipment, surgical navigation systems, and patient handling solutions. Its subsidiary, Stryker Osteosynthesis, focuses on craniomaxillofacial and traumatology-related products. The company maintains a strong presence in over 100 countries, highlighting its global reach and influence.

Medtronic is another major player, recognized for its extensive portfolio across healthcare verticals such as patient monitoring, renal care, pulse oximetry, energy-based surgical devices, gastrointestinal solutions, brain monitoring, and advanced mechanical ventilation systems. Its broad product range positions it as one of the most diversified companies in the global medical device industry.

Abbott, a healthcare and pharmaceutical leader, operates across four main business segments: pharmaceuticals, medical devices, nutrition, and diagnostics. With an active presence in more than 150 countries, Abbott’s operations span research, manufacturing, sales, and distribution. The company continues to drive innovation, particularly in cardiovascular devices, diabetes care, and diagnostic technologies, reinforcing its leadership position.

Emerging players are also beginning to impact the competitive landscape. Gelmetix focuses on treating chronic lower back pain caused by intervertebral disc degeneration. Its polymer gel product is designed to restore disc integrity and alleviate long-term pain. LOCI Orthopedics specializes in orthopedic devices and technologies, particularly solutions for orthopedic extremities. These companies, though smaller, are contributing to innovation by targeting niche but high-potential areas of the market.

Key Players

• Stryker
• Cardinal Health
• Eli Lily and Company
• Intuitive Surgical
• Edwards Lifesciences Corporation
• BD
• Danaher
• 3M
• Abbott
• Baxter
• B. Braun SE
• GE Healthcare
• Johnson & Johnson Services, Inc.
• Medtronic
• Boston Scientific Corporation

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The U.S. medical device manufacturers market is poised for steady growth, driven by an aging population, rising chronic conditions, and increasing demand for minimally invasive procedures. Expanding geographic reach, strategic acquisitions, and technological advancements are enhancing competitiveness across diverse medical segments. While the others category dominates due to demand in dental, ENT, imaging, and wound care, cardiology devices are set to grow the fastest, reflecting the urgency of addressing cardiovascular health. With strong contributions from established players such as Stryker, Medtronic, and Abbott, along with innovative efforts from emerging firms, the market will remain central to advancing healthcare outcomes.